Company Profile
MaxCyte Stock Price, News & Catalysts
- Ticker:
- MXCT
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United Kingdom and listed in the U
Stock performance
1.27 USD (+2.42%)
Close
Last updated: August 12, 2026
132M USD
Market cap
Why the stock is moving
The latest monitored company update is “MaxCyte Reports Second Quarter 2026 Financial Results.” The corresponding closing-price reaction is not yet available.
Company overview
Cell Engineering Platform
MaxCyte provides electroporation systems and services used to engineer cells for research, clinical development, and commercial cell therapies.
ExPERT Platform
The ExPERT instrument family uses Flow Electroporation technology to introduce molecules into diverse cell types from laboratory through commercial scale while preserving cell viability and function.
Strategic Platform Licenses
Cell-therapy developers use MaxCyte technology under Strategic Platform License agreements that can generate instrument, consumable, milestone, and commercial revenue as partnered programs advance.
SeQure Services
SeQure expands the offering into gene-editing risk assessment and analytical services, helping developers evaluate editing outcomes and potential off-target effects.
Enterprise Partnerships
MaxCyte also licenses multiple platform technologies at the enterprise level. Its Genentech agreement extends this model across research, clinical development, and potential commercial manufacturing workflows.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of MaxCyte (MXCT)?
MaxCyte (MXCT) most recently closed at 1.27 USD, a +2.42% move versus the previous session.
What is the market cap of MaxCyte (MXCT)?
MaxCyte currently has a market capitalization of 132M USD on BioPharmSignal.
What does MaxCyte do?
Cell Engineering Platform MaxCyte provides electroporation systems and services used to engineer cells for research, clinical development, and commercial cell therapies. ExPERT Platform The ExPERT instrument family uses Flow Electroporation technology to introduce molecules into diverse cell types from laboratory through commercial scale while preserving...
On which exchange is MXCT stock listed?
MaxCyte (MXCT) is associated with NASDAQ, United Kingdom and listed in the U, Biopharma.
What is Cell?
Cell Engineering Platform MaxCyte provides electroporation systems and services used to engineer cells for research, clinical development, and commercial cell therapies.
Which conditions is MaxCyte targeting with Cell?
Cell Engineering Platform MaxCyte provides electroporation systems and services used to engineer cells for research, clinical development, and commercial cell therapies. ExPERT Platform The ExPERT instrument family uses Flow Electroporation technology to introduce molecules into diverse cell types from laboratory through commercial scale while preserving...
What is Engineering?
Cell Engineering Platform MaxCyte provides electroporation systems and services used to engineer cells for research, clinical development, and commercial cell therapies.
What is Platform?
Cell Engineering Platform MaxCyte provides electroporation systems and services used to engineer cells for research, clinical development, and commercial cell therapies.